These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 6145828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Drug therapy of pituitary neoplasms].
    Kato Y.
    Nihon Naibunpi Gakkai Zasshi; 1987 Dec 20; 63(12):1429-38. PubMed ID: 2897313
    [No Abstract] [Full Text] [Related]

  • 4. Comment on "Non-surgical treatment of hormone-secreting pituitary tumors".
    Dobson M, Del Porto L, Maartens NF.
    J Clin Neurosci; 2010 Sep 20; 17(9):1220-1. PubMed ID: 20570519
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [TSH-secreting pituitary adenomas].
    Beckers A, Hennen G, Reznik M, Thibaut A, Stevenaert A.
    Rev Med Liege; 1988 May 15; 43(10):396-402. PubMed ID: 2899901
    [No Abstract] [Full Text] [Related]

  • 8. Apoplexy in a corticotrophin-secreting pituitary macroadenoma: a case report and review of the literature.
    Haboubi H, Azam I, Edavalath M, Redfern RM, Price DE, Stephens JW.
    QJM; 2010 Aug 15; 103(8):607-9. PubMed ID: 20085992
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs.
    Rabbiosi S, Peroni E, Tronconi GM, Chiumello G, Losa M, Weber G.
    Thyroid; 2012 Oct 15; 22(10):1076-9. PubMed ID: 22947349
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr 15; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
    Blevins LS, Christy JH, Khajavi M, Tindall GT.
    J Clin Endocrinol Metab; 1998 Jan 15; 83(1):63-7. PubMed ID: 9435417
    [Abstract] [Full Text] [Related]

  • 16. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
    Fischler MP, Reinhart WH.
    J Endocrinol Invest; 1999 Jan 15; 22(1):64-5. PubMed ID: 10090139
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential indications for somatostatin analogs in Cushing's syndrome.
    Arnaldi G, Polenta B, Cardinaletti M, Boscaro M.
    J Endocrinol Invest; 2005 Jan 15; 28(11 Suppl International):106-10. PubMed ID: 16625858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The role of somatostatin analogues in the treatment of hypophyseal adenomas].
    Losa M, Mortini P, Giovanelli M.
    Minerva Endocrinol; 2003 Mar 15; 28(1):39-51. PubMed ID: 12621362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.